Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hydrochloric Acid | 1 | 2019 | 76 | 0.680 |
Why?
|
Brachiocephalic Trunk | 1 | 2018 | 40 | 0.630 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2018 | 108 | 0.590 |
Why?
|
Gastric Mucosa | 1 | 2019 | 604 | 0.540 |
Why?
|
Liver Neoplasms | 5 | 2024 | 4319 | 0.350 |
Why?
|
Laparoscopy | 3 | 2023 | 2036 | 0.280 |
Why?
|
Atherosclerosis | 2 | 2020 | 3408 | 0.260 |
Why?
|
Hepatectomy | 4 | 2023 | 557 | 0.260 |
Why?
|
Bile Duct Neoplasms | 2 | 2022 | 605 | 0.250 |
Why?
|
CCN Intercellular Signaling Proteins | 1 | 2024 | 24 | 0.240 |
Why?
|
Macrophages | 2 | 2020 | 5769 | 0.240 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2024 | 112 | 0.230 |
Why?
|
Candida | 1 | 2023 | 172 | 0.210 |
Why?
|
Interferon Type I | 1 | 2024 | 562 | 0.180 |
Why?
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2020 | 52 | 0.170 |
Why?
|
Cholesterol, Dietary | 1 | 2020 | 224 | 0.170 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2019 | 86 | 0.170 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2024 | 328 | 0.170 |
Why?
|
Melanoma, Experimental | 1 | 2022 | 560 | 0.160 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2022 | 2297 | 0.160 |
Why?
|
Pancreaticoduodenectomy | 1 | 2020 | 509 | 0.140 |
Why?
|
Liver Cirrhosis | 2 | 2024 | 1935 | 0.130 |
Why?
|
Lipoproteins, LDL | 1 | 2018 | 642 | 0.120 |
Why?
|
Necrosis | 1 | 2019 | 1611 | 0.120 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1096 | 0.120 |
Why?
|
Melanoma | 2 | 2024 | 5709 | 0.120 |
Why?
|
Gastrectomy | 1 | 2019 | 672 | 0.120 |
Why?
|
Apolipoproteins E | 1 | 2020 | 1444 | 0.110 |
Why?
|
Autophagy | 2 | 2020 | 1326 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2022 | 5369 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1157 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1787 | 0.110 |
Why?
|
Interleukin-1beta | 1 | 2018 | 999 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6935 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2024 | 8552 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3877 | 0.090 |
Why?
|
Suicide, Attempted | 1 | 2019 | 1402 | 0.090 |
Why?
|
Cholesterol | 1 | 2018 | 2904 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4352 | 0.070 |
Why?
|
Mice | 6 | 2024 | 81533 | 0.060 |
Why?
|
Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2024 | 17 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5821 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12975 | 0.060 |
Why?
|
Janus Kinases | 1 | 2024 | 248 | 0.050 |
Why?
|
STAT1 Transcription Factor | 1 | 2024 | 341 | 0.050 |
Why?
|
Constriction | 1 | 2023 | 168 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18253 | 0.050 |
Why?
|
Interferon-beta | 1 | 2024 | 345 | 0.050 |
Why?
|
Animals | 7 | 2024 | 168467 | 0.050 |
Why?
|
Hospitals, University | 1 | 2023 | 564 | 0.050 |
Why?
|
Humans | 16 | 2024 | 761572 | 0.050 |
Why?
|
Signal Transduction | 1 | 2024 | 23447 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2022 | 296 | 0.050 |
Why?
|
Survival Analysis | 2 | 2024 | 10090 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 629 | 0.040 |
Why?
|
Diet | 1 | 2018 | 8075 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2024 | 921 | 0.040 |
Why?
|
Milk | 1 | 2022 | 443 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2020 | 510 | 0.040 |
Why?
|
Meat | 1 | 2022 | 584 | 0.040 |
Why?
|
Vena Cava, Inferior | 1 | 2023 | 458 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2022 | 852 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 568 | 0.040 |
Why?
|
Length of Stay | 2 | 2023 | 6426 | 0.040 |
Why?
|
Clone Cells | 1 | 2022 | 1659 | 0.040 |
Why?
|
Plasmids | 1 | 2022 | 2269 | 0.040 |
Why?
|
Hepatocytes | 1 | 2024 | 1233 | 0.040 |
Why?
|
Apoptosis | 2 | 2024 | 9489 | 0.030 |
Why?
|
Postoperative Complications | 3 | 2023 | 15633 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2141 | 0.030 |
Why?
|
DNA Replication | 1 | 2022 | 1418 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12463 | 0.030 |
Why?
|
Homozygote | 1 | 2020 | 1776 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22172 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 2057 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2023 | 80646 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2022 | 2827 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5247 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2022 | 6815 | 0.020 |
Why?
|
Male | 4 | 2024 | 360842 | 0.020 |
Why?
|
Prognosis | 2 | 2022 | 29629 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2023 | 64684 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6766 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2024 | 10448 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2020 | 1533 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9420 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 3085 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16986 | 0.020 |
Why?
|
Liver | 1 | 2023 | 7529 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11121 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9177 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 74213 | 0.020 |
Why?
|
Adult | 1 | 2019 | 221203 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14416 | 0.010 |
Why?
|
Female | 4 | 2024 | 392686 | 0.010 |
Why?
|
Lung | 1 | 2022 | 10002 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13510 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16592 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41493 | 0.010 |
Why?
|
Aged | 1 | 2023 | 169310 | 0.010 |
Why?
|
Concepts
(100)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_